Reflow Medical, Inc. is a privately held company dedicated to developing simple, yet sophisticated, technologies that facilitate procedures used for treating cardiovascular disease. Our devices are compatible with the physician’s choice of guidewire and technique, and allow treatment of a wide variety of vasculature.
Working with physicians to find solutions for unmet clinical needs, our team has produced innovative medical devices that are proven in practices every day, with more in development. Together, our goal is to continually improve patient outcomes.
“Our patented Wingman Crossing Catheter technology has proven to be a game changer. It promotes efficiency and safety in performing a range of cardiovascular procedures.”
– Isa Rizk
Co-Founder & Chief Executive Officer
Isa co-founded Reflow Medical Inc. and is Chief Executive Officer for the Company. Prior to founding ReFlow Medical, Isa served at Intersect Partners, a medical device incubator, where he helped found and manage several companies including Altura Medical, Mindframe Inc., and Reshape Medical. Isa was Director of Research and Development at Edwards Lifesciences Aortic Heart Valve Division, developing the Magna Ease heart valve. Earlier in his career, Isa was involved in Research and Development at Intraluminal Therapeutics, working on their peripheral and coronary chronic total occlusion system. He held R&D positions with Baxter Cardiovascular and Intramed Laboratories.
Isa earned an MBA from USC Marshall School of Business and a Bachelor of Science degree in Mechanical Engineering from San Diego State University. He is the co-founder and vice president of SD BACKed, a San Diego-based non-profit benefit and aid organization dedicated to underprivileged and at-risk children.
“We’re committed to developing devices that give physicians an unprecedented level of visibility and control in crucial situations.”
– John Fulkerson
Co-Founder and Chief Operating Officer
John co-founded Reflow Medical Inc. and serves as Chief Operating Officer for the Company. Prior to founding Reflow Medical, John was affiliated with, Intersect Partners, a medical device incubator, where he helped found and manage several companies including Altura Medical, Mindframe Inc., and Reshape Medical. John was Sr. Director of Research and Development at Edwards Lifesciences Peripheral Vascular Division, developing the LifeStent Peripheral Stent, which was acquired by C.R. Bard in 2007. Earlier in his career, John was Manager of New Product Development at Cordis J&J developing and commercializing their Hepacoat coronary stent system. He also held management positions with Syntheon, Baxter Cardiovascular and Intramed Laboratories. John has been awarded with numerous US patents, with several pending. He received his Bachelor of Science degree in Mechanical Engineering from San Diego State University.
“There is nothing more rewarding than knowing our products help saves lives daily.”
– Jose Marques
Vice President of Commercialization & Marketing
Jose serves as Vice President of US Commercialization and Market Development for ReFlow Medical. Jose has been an accomplished sales and marketing executive with a passion to help patients for over 36 years. Prior to joining ReFlow Medical, Jose served as a Board Member of Lutonix and Director with the responsibility for the successful OUS Strategic Marketing and Commercialization of the Lutonix DEB technology. He has extensive knowledge in a medical device market that rapidly changes, requiring constant learning and adaptation keeping up with new algorithms of clinical treatment. Jose joined Bard, as a Regional Market Development Manager, to ensure the success of the acquisition, integration, training and execution of the Crosser CTO sales strategy in the peripheral market. Jose was involved in developing the CTO crossing catheter coronary and peripheral market with FlowCardia, a successful start-up, as Regional Director of Sales which was acquired by C.R. Bard in 2010. Prior, Jose served as Director of Sales for Edwards Lifesciences in the Peripheral Vascular Division, successfully commercializing the LifeStent which was acquired by C.R. Bard in 2007. Previously, Jose had a successful career in Cardiology Sales and Marketing where he was responsible for launching numerous coronary medical devices which significantly improved patient care. Jose held various executive management positions spanning over 24 years with Cordis J&J and Cordis, prior to the Johnson and Johnson acquisition, where he demonstrated a strong track record of significant achievement, including several US patents, with increasing responsibility and leadership. Prior to entering the medical device industry, Jose held key management roles in the Financial market arena. He holds an MSM, specialties in Finance and Marketing from Florida International University Graduate School of Business and a Bachelor of Science in Criminal Justice from Florida International University.
“With new products in the pipeline, we’re positioned to change, for the better, how surgeons perform certain life-saving procedures. ”
– Obinna L. Adighije
Vice President of Strategy
Obinna serves as Vice President of Strategy for Reflow Medical Inc. He has over 25 years of experience in the medical device industry in various executive management roles. Prior to joining Reflow Medical, Obinna served as the Senior Vice President Sales & Marketing and Business Development at Celenova. He also served as Vice President, Business Development & Strategy at Spectranetics, where he strengthened the company’s focus in the peripheral vascular space. He was also responsible for the acquisition of key product lines from Kensey Nash. Prior, Mr. Adighije was a senior director of business development and strategic marketing for Edwards Life sciences, where he led development operations for the firm’s vascular division. While at Edwards, he was instrumental in the acquisition, development and introduction of the Lifestent self-expanding stent. Prior to that, he was a senior global group marketing manager for AVE/Medtronic Interventional Vascular where he was responsible in launching key coronary stents and PTCA balloons. He was an associate Business development manager at ACS/ Guidant. He holds an MBA from Jacksonville State University, and is a CPA who holds a Bachelor of Business degree in Accounting from Kansas State University.
“People look to us for safe and reliable solutions – it’s a responsibility we take seriously as industry leaders in the US and abroad.”
– Rebecca Pine
Vice President of Regulatory Affairs/Quality Assurance
Becky serves as Vice President of Regulatory Affairs/Quality Assurance for Reflow Medical, Inc. She has over 20 years of experience in the medical device industry, both at industry-leading corporations and small business start-ups. Her background includes all aspects of domestic and international medical device regulatory and quality management for a wide range of products including cardiovascular, orthopedic, electromedical devices, nuclear medicine and in vitro diagnostics (IVD). She has authored numerous successful 510(k)’s, original PMAs, PMA Supplements, technical files and design dossiers. She received her Bachelor of Science degree from the University of New York (Regents College) and is a member of the Regulatory Affairs Professionals Society.
“Our team is constantly innovating our products to better serve physicians.”
– Teo Jimenez
Vice President of Research and Development
Teo has over 20 years of R&D experience developing market leading medical devices for treatment of vascular and cardiac diseases. With this experience, he has led engineering teams to develop strategically aligned technologies from concept, clinical application and into commercialization to treat and save patient lives. His many contributions include the design and development of devices to treat abdominal aortic aneurysms, atrial fibrillation, peripheral stenting and various cardiac valve technologies from a surgical and transcatheter perspective.
Prior to joining ReFlow Medical, he has worked at various large and small companies which include Baxter Healthcare, Biosense Webster (Johnson and Johnson Company), Edwards Lifesciences and most recently at JenaValve Technologies where he was responsible for leading the development and clinical use of the next generation transfemoral/transapical system for aortic valve diseases.Teo received his B.S. in Engineering Science at the University of Florida, Gainesville. Teo has several issued patents and patent pending applications.
Gary M. Ansel, MD
Interventional Cardiology – Columbus, OH
John R. Laird, MD
Interventional Cardiology – Sacramento, CA
Mahmood K Razavi, MD
Interventional Radiology – Orange, CA
Andrej Schmidt, MD
Cardiologist, Angiologist – Leipzig, Germany